1. Home
  2. VLY vs PRAX Comparison

VLY vs PRAX Comparison

Compare VLY & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valley National Bancorp

VLY

Valley National Bancorp

HOLD

Current Price

$14.17

Market Cap

8.1B

Sector

Finance

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$374.55

Market Cap

7.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VLY
PRAX
Founded
1927
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
7.1B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
VLY
PRAX
Price
$14.17
$374.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
15
Target Price
$14.65
$572.13
AVG Volume (30 Days)
6.4M
412.1K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
3.31%
N/A
EPS Growth
46.38
N/A
EPS
0.57
N/A
Revenue
N/A
N/A
Revenue This Year
$23.58
N/A
Revenue Next Year
$8.51
$7,758.26
P/E Ratio
$24.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.64
$37.25
52 Week High
$15.20
$392.70

Technical Indicators

Market Signals
Indicator
VLY
PRAX
Relative Strength Index (RSI) 39.67 60.36
Support Level $13.30 $291.44
Resistance Level $15.00 N/A
Average True Range (ATR) 0.29 20.08
MACD -0.07 1.86
Stochastic Oscillator 12.05 83.46

Price Performance

Historical Comparison
VLY
PRAX

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: